# Rezo Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rezo-therapeutics

- Industry: Biotechnology
- Headquarters: South San Francisco, US
- Website: www.rezotx.com
- Total disclosed funding: $15M
- Latest round: Series A (Nov 17, 2022)
- Investors on record: 6

## About

Based in California, US, and co-founded by Nevan Krogan (CEO), Kevan Shokat, Sourav Bandyopadhyay (CSO), Natalia Jura, George Scangos (Chairperson), and Norbert Bischofbergerin, Rezo Therapeutics, Inc. operates as a biopharmaceutical company that focuses on developing a technology platform to enhance the success rate of drug development. In November 2022, the firm raised USD 78 million in series A funding co-led by new investors a16z, Norwest Venture Partners, and SR One, with participation from other investors Hawktail Management, Liquid 2 Ventures, and SV Angel. 

The company offers a Sequence to Systems to Drugs (SSD) platform that through computational methods enables the integration of data from proteomics, genetics, structural biology, and chemical biology and creates comprehensive maps of molecular disease networks to provide more complete and rapid view of mechanisms that causes disease. The platform through artificial intelligence and machine learning, identifies and study disease-causing protein and genetic interactions, and elevates the rate of medication development and its effectiveness for a range of diseases. Rezo as of January 2023 is initially focusing on oncology.

The company plans to utilize its November 2022 funding to support its product research and development.

## Funding rounds

- Series A, Nov 17, 2022, $15M — Norwest Venture Partners, SR One, Andreessen Horowitz, SV Angel, Liquid 2 Ventures, Hawktail

## Investors

- Norwest Venture Partners (https://capitalatlas.ai/funds/norwest-venture-partners) — Series A
- SR One (https://capitalatlas.ai/funds/sr-one) — Series A
- Andreessen Horowitz (https://capitalatlas.ai/funds/andreessen-horowitz) — Series A
- SV Angel (https://capitalatlas.ai/funds/sv-angel) — Series A
- Liquid 2 Ventures (https://capitalatlas.ai/funds/liquid-2-ventures) — Series A
- Hawktail (https://capitalatlas.ai/funds/hawktail) — Series A